A randomized, controlled field study to assess the efficacy and safety of lotilaner (Credelio™) in controlling fleas in client-owned cats in Europe

BACKGROUND: Lotilaner is a new isoxazoline developed as an oral ectoparasiticide for cats and dogs. Its safety, rapid killing onset of action and sustained speed of fleas and ticks kill for a minimum of one month after administration, were demonstrated in a number of laboratory studies in cats. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalleri, Daniela, Murphy, Martin, Seewald, Wolfgang, Nanchen, Steve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044040/
https://www.ncbi.nlm.nih.gov/pubmed/30001744
http://dx.doi.org/10.1186/s13071-018-2971-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044040/
https://www.ncbi.nlm.nih.gov/pubmed/30001744
http://dx.doi.org/10.1186/s13071-018-2971-9

Ejemplares similares